Research Reports published by GEOJIT BNP PARIBAS

PI Industries Ltd.    
20 Nov 2020
2359.60
-2.56%
buy
Geojit BNP Paribas
PI Industries manufactures plant protection & specialty plant nutrient products and solutions under its agri-inputs business. It is also one of India's leading custom synthesis (CSM) companies engaged in providing contract...
PI Industries Ltd. is trading above all available SMAs
Petronet LNG Ltd.    
20 Nov 2020
258.35
2.28%
buy
Geojit BNP Paribas
Petronet LNG's volume demand reaching pre-COVID levels, improvement in operational efficiency, and commissioning of the Kochi-Mangalore pipeline will boost performance in upcoming quarters. Hence, we reiterate our BUY rating on the stock with a revised target price of Rs. 327 based on 15.0x FY22E adj. EPS. Operational efficiency improved operating margins PLNG's Q2FY21 revenue fell 33.4% YoY to Rs. 6,236cr (+27.7% QoQ), on lower gas prices partially offset by increase in LNG volumes processed (1.6% YoY to 254 TBTUs)....
Petronet LNG Ltd. is trading above all available SMAs
NBCC (India) Ltd.    
20 Nov 2020
26.10
-0.19%
Geojit BNP Paribas
Order book remains strong at Rs72,000cr, however orders worth ~Rs17,000cr were in execution stage and NBCC targets to take total projects under execution to ~Rs27,000cr in FY21. NBCC got clearance for Nauroji Nagar projects while Netaji Nagar & Sarojini Nagar projects are awaiting forest clearances. We cut FY21E/22E EPS estimates by 47%/28% due to fall in PMC margins and slow pace in real estate business. We value NBCCs core business at a P/E of 13x on FY22E EPS &...
Geojit BNP Paribas decreased Hold price target of NBCC (India) Ltd. to 26.0 on 20 Nov, 2020.
Jubilant Foodworks Ltd.    
20 Nov 2020
2543.10
-2.94%
buy
Geojit BNP Paribas
Outlook improves with the ongoing growth momentum across delivery and take-away channels and expected recovery from Dine-in. Therefore, we upgrade our rating on the stock to ACCUMULATE with a revised price target of Rs. 2,830 based on 63x Dec 2022E adj. EPS....
default
Jubilant Foodworks Ltd. is trading above all available SMAs
Tata Steel Ltd.    
19 Nov 2020
548.30
0.96%
buy
Geojit BNP Paribas
Tata Steel is a leader in the global steel industry with operations spanning over 26 countries with key operations in India, Netherlands and United Kingdom. Tata steel primarily caters to customers in automotive,...
Geojit BNP Paribas upgraded Tata Steel Ltd. to Buy with a price target of 614.0 on 19 Nov, 2020.
Shree Cements Ltd.    
19 Nov 2020
24243.55
-0.91%
buy
Geojit BNP Paribas
Shree Cement Limited provides building materials. The company manufactures and sells cement and cement products in India. The company currently operates with a total cement capacity of 44.4mpta of which...
Shree Cements Ltd. has gained 21.76% in the last 6 Months
Minda Industries Ltd.    
19 Nov 2020
380.80
4.37%
buy
Geojit BNP Paribas
Minda Industries Ltd (MIL) is a diversified auto ancillary supplier, manufacturing products such as switches, horns & lights. MIL holds a leadership position in switch business with a market share of 67%. MIL's diversified portfolio in the auto component has led the revenue to grow by 8%YoY. This was largely on account of demand for superior product related to BS-VI vehicles. Enhanced safety features and premiumisation of vehicle will further lead to value migration and higher kit value per vehicle for...
Chola Wealth Direct released a report for Minda Industries Ltd. on 20 Nov, 2020.
Voltas Ltd.    
18 Nov 2020
778.40
2.37%
buy
Geojit BNP Paribas
With volume recovery in both UCP and EMP in upcoming quarters, we expect the topline to improve gradually. However, focus remains on the firm's ability to control costs in order to recoup margins. Hence we...
Geojit BNP Paribas upgraded Voltas Ltd. to Hold with a price target of 848.0 on 18 Nov, 2020.
Natco Pharma Ltd.    
18 Nov 2020
913.15
0.19%
buy
Geojit BNP Paribas
Q2FY21 on the back of growth in exports of formulations, APIs as well as one-offs like the Revlimid settlement income. India business continued its de-growth during the quarter with a YoY decline of 11% on account of lower oncology and Hep-C sales. The company has stated that it would look to launch the highly anticipated Revlimid in the U.S during FY22. Natco expects the launch of its agrochemical molecules by the end of the year, pending regulatory approval....
Geojit BNP Paribas downgraded Natco Pharma Ltd. to Sell with a price target of 827.0 on 18 Nov, 2020.